Clinical Trial

Thera-Clean® Microbubbles System in Patients With Skin Diseases

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Summary
Thera-Clean® Microbubble has proved to improve skin conditions in animals, however little research has been done regarding human subjects. Microbubble technology is a chemical-free therapeutic aimed at clearing foreign and organic matter from hair follicles, eliminating odors, and reducing itch. This hydrotherapy is said to aid in the healing process of inflamed and distressed tissue, relieve pain, and serve to remove contaminated tissue. This study will evaluate the change in skin conditions from the use of Thera-Clean® Microbubble for cleansing and debriding wounds from selected subjects focused on patients with inflammatory skin disease (epidermolysis bullosa, ichthyosis, atopic dermatitis and/or psoriasis). Proper wound care to prevent infection is vitally important for these patients and the options of therapeutics are limited. This study will evaluate the change in skin conditions from the use of Thera-Clean® Microbubble for cleansing and debriding lesional skin.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-25.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-01-30
Trial Details
NCT Number NCT07050810
Lead Sponsor Northwestern University
Conditions Epidermolysis Bullosa, Ichthyosis, Atopic Dermatitis, Psoriasis
Enrollment 20 participants
Start Date 2026-01-13
Primary Completion 2026-12 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-03